Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

TheraQuest meets with U.S., U.K., Canadian authorities regarding TQ-1011

Aug. 16, 2004

GB Therapeutics acquires license for Chiesi's NMDA antagonist

Aug. 16, 2004

Neuropharma raises funding via private placement

Aug. 12, 2004

Neurogen scientists prepare new vanilloid VR1 antagonists for pain management

Aug. 12, 2004

Bryostatin 1 improves pathophysiology and cognitive impairment in mouse model of AD

Aug. 12, 2004

Pulmonary administration of levodopa improves efficacy in rat model of Parkinson's disease

Aug. 12, 2004

beta-Amyloid immunization improves cognition in a mouse model of Alzheimer's disease

Aug. 12, 2004

Merck & Co. and DOV enter agreement for triple uptake inhibitor development

Aug. 11, 2004

Frovatriptan provides relief for menstrual associated migraine

Aug. 11, 2004

AstraZeneca presents novel GSK-3 inhibitors for AD and other uses

Aug. 11, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...